Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update Meeting Abstract


Authors: Sherman, E.; Wirth, L.; Shah, M.; Cabanillas, M.; Robinson, B.; Italiano, A.; Laskin, J.; Subbiah, V.; Drilon, A.; Wright, J.; French, P.; Soldatenkova, V.; Kroiss, M.; Weiler, D.
Abstract Title: Selpercatinib efficacy and safety in patients with RET-altered thyroid cancer: A clinical trial update
Meeting Title: Swiss Oncology and Hematology Congress (SOHC)
Journal Title: Swiss Medical Weekly
Volume: 151
Meeting Dates: 2021 Nov 18-20
Meeting Location: Zürich, Switzerland
ISSN: 1424-7860
Publisher: E M H Swiss Medical Publishers Ltd  
Date Published: 2021-11-17
Start Page: w30107
Language: English
ACCESSION: WOS:000760549700025
PROVIDER: wos
PUBMED: 34846116
DOI: 10.4414/smw.2021.w30107
Notes: Meeting Abstract: O24 -- Located on page 15S of the publication -- Supplementum 255 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Eric J Sherman
    342 Sherman
  2. Alexander Edward Drilon
    633 Drilon